一、行情回顾 沪指午后震荡走强，重返4100点上方，创业板指探底回升。煤炭板块集体爆发，中煤能源、潞安环能等十余股涨停。太空光伏概念延续涨势，晶科能源、 TCL中环等多股涨停。民航板块大涨，华夏航空、中国东航涨停。地产股继续反弹，京投发展、荣安地产等涨停。下跌方面，AI应用方向下挫，引力传媒、 天地在线跌停。个股涨多跌少，沪深京三市超3200股飘红，今日成交2.5万亿。 二、当日热点 1.煤炭 煤炭板块今日大涨，陕西黑猫、中煤能源、云煤能源、山西焦化等多股涨停。 据智通财经报道，印尼矿业官员周二表示，由于印尼政府提出大幅减产计划，该国矿商已暂停现货煤炭出口。印尼上月向主要矿商下达的产量配额比2025年 水平降低40%至70%，作为该国提振煤价计划的一部分。印尼主要行业协会反对此举，警告称可能引发裁员和矿山关闭。 机构称参考过去几年印尼官方对煤炭产量预估与实际原煤产量差距较大。例如2024年预估7.1亿吨，2025年预估7.35亿吨，这些官方预估产量都低于当年的实 际产量。如果按照印尼政府官员口径，把原煤产量从8.17亿吨砍至6亿吨，减量的幅度将高达36.2%。 此外，今日焦煤期货大涨3.6%。 | 股票名称 ...

Market Overview - The market experienced a strong upward trend, with the Shanghai Composite Index stabilizing above 3500 points. Real estate stocks surged in the afternoon, with several stocks such as Huaxia Happiness and Deep Deep Housing A hitting the daily limit. Major financial stocks continued to perform well, with the four major banks reaching historical highs. The photovoltaic sector also saw a rebound, particularly in the organic silicon segment, with multiple stocks hitting the daily limit. Overall, over 2800 stocks in the Shanghai and Shenzhen markets rose, with a total transaction volume of 1.51 trillion yuan [1]. Real Estate Sector - The real estate sector saw significant gains, with stocks like Sifang New Materials and Yucheng Development hitting the daily limit. The National Development and Reform Commission emphasized increasing investment in new urbanization, which catalyzed the market. Additionally, around 20 cities, including Chongqing and Shenyang, have supported and optimized the "commercial to public" policy this year [4][5]. - According to the China Index Academy, to alleviate insufficient effective demand, some cities may further relax purchase and loan restrictions, while also accelerating the construction of affordable housing and optimizing land supply structures to promote a stable and healthy real estate market [5]. Pharmaceutical Sector - The pharmaceutical sector remained active, with stocks like Saily Medical and Lianhuan Pharmaceutical hitting the daily limit. Merck announced a $10 billion acquisition of Verona Pharma to enhance its COPD treatment product line. The National Healthcare Security Administration and the National Health Commission issued measures to support the high-quality development of innovative drugs, which include 16 initiatives to strengthen support for innovative drug research and development [6][7]. - The trend of Chinese innovative drugs going global is expected to enhance profitability and market space, leading to improved industry valuation levels. The adjustment plan for the national medical insurance directory and commercial insurance innovative drug directory is anticipated to be implemented in November [8]. Hydrogen Energy Sector - The hydrogen energy sector showed strong performance, with stocks like Huaguang Huaneng and Tianwo Technology hitting the daily limit. The emphasis on developing hydrogen energy as part of a new energy system was highlighted during a recent inspection by the General Secretary in Shanxi [9][10]. - The strategic position of hydrogen energy has been established, with local policies supporting its development. The renewable energy green hydrogen production capacity is expected to reach over 400,000 tons by 2025 in the Sanbei region. The construction of hydrogen pipelines is also entering a capital-intensive phase, with major state-owned enterprises as primary investors [10]. Other Notable Sectors - Other sectors such as consumer goods and finance showed localized activity, while military and digital currency high-priced stocks experienced declines [11]. - The market is also witnessing a focus on performance as the mid-year reporting period approaches, with expectations for continued improvement in the performance of innovative drugs and their supply chains [8].